Document Type

Article

Publication Date

3-1-2022

Abstract

The inhibition of dipeptidyl peptidase-IV (DPP-IV) and the release of glucagon-like peptide-1 (GLP-1) could normalize blood glucose levels in diabetic patients. This study evaluated the susceptibility of whey proteins to enzyme hydrolysis and the antidiabetic properties of protein hydrolysates from β-lactoglobulin (β-LG) and α-lactalbumin (α-LA) solutions compared with whey protein isolate (WPI) solution treated at different heating temperatures (65, 75, and 85◦ C). α-LA hydrolysate provided the lowest degree of hydrolysis (DH). Those heating temperatures did not significantly affect the DH of all protein hydrolysates. α-LA hydrolysate significantly increased GLP-1 levels and DPP-IV inhibitory activity more than β-LG hydrolysate. WPI hydrolysate inhibited DPP-IV activity less than an α-LA hydrolysate, but they were no significant differences for GLP-1 release activity. Heat treatment could affect the antidiabetic properties of all protein hydrolysates. Heating at 75◦ C resulted in greater inhibition of the activity of DPP-IV than at 65 and 85◦ C. The highest increase in GLP-1 release was also observed by heating at 75◦ C. The recently obtained information is useful for the utilization of α-LA, heated at 75◦ C for 30 min, in the preparation of antidiabetic food supplements.

Publication Source (Journal or Book title)

Foods

Download

Share

COinS